Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

NeuroPace (NPCE) Return on Capital Employed (2021 - 2025)

Historic Return on Capital Employed for NeuroPace (NPCE) over the last 5 years, with Q3 2025 value amounting to 0.21%.

  • NeuroPace's Return on Capital Employed rose 800.0% to 0.21% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.21%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.25% for FY2024, which is 400.0% up from last year.
  • As of Q3 2025, NeuroPace's Return on Capital Employed stood at 0.21%, which was up 800.0% from 0.22% recorded in Q2 2025.
  • In the past 5 years, NeuroPace's Return on Capital Employed ranged from a high of 0.13% in Q3 2021 and a low of 0.39% during Q1 2023
  • Over the past 5 years, NeuroPace's median Return on Capital Employed value was 0.29% (recorded in 2024), while the average stood at 0.28%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first tumbled by -2300bps in 2022, then skyrocketed by 1000bps in 2024.
  • Quarter analysis of 5 years shows NeuroPace's Return on Capital Employed stood at 0.19% in 2021, then crashed by -107bps to 0.38% in 2022, then rose by 19bps to 0.31% in 2023, then increased by 13bps to 0.27% in 2024, then increased by 22bps to 0.21% in 2025.
  • Its last three reported values are 0.21% in Q3 2025, 0.22% for Q2 2025, and 0.22% during Q1 2025.